Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial

© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Early initiation of antiretroviral treatment (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 part...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jessica M. Fogel, Sarah E. Hudelson, San San Ou, Stephen Hart, Carole Wallis, Mariza G. Morgado, Shanmugam Saravanan, Srikanth Tripathy, Laura Hovind, Estelle Piwowar-Manning, Devin Sabin, Marybeth McCauley, Theresa Gamble, Xinyi C. Zhang, Joseph J. Eron, Joel E. Gallant, Johnstone Kumwenda, Joseph Makhema, Nagalingeswaran Kumarasamy, Suwat Chariyalertsak, James Hakim, Sharlaa Badal-Faesen, Victor Akelo, Mina C. Hosseinipour, Breno R. Santos, Sheela V. Godbole, Jose H. Pilotto, Beatriz Grinsztejn, Ravindre Panchia, Kenneth H. Mayer, Ying Q. Chen, Myron S. Cohen, Susan H. Eshleman
Format:	Journal
Published:	2018
Subjects:	Medicine
Online Access:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84976315930&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56126
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial
by: Fogel J., et al.
Published: (2017)

Comparison of hepatitis b virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical trial: HPTN 052
by: Amy E. Greer, et al.
Published: (2018)

Comparison of hepatitis b virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical trial: HPTN 052
by: Amy E. Greer, et al.
Published: (2018)

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
by: Philip J. Palumbo, et al.
Published: (2018)

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV prevention trials network 052)
by: Jessica M. Fogel, et al.
Published: (2018)

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV prevention trials network 052)
by: Jessica M. Fogel, et al.
Published: (2018)

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
by: Susan H. Eshleman, et al.
Published: (2018)

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
by: Susan H. Eshleman, et al.
Published: (2018)

Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial
by: Susan H. Eshleman, et al.
Published: (2018)

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
by: Eshleman S., et al.
Published: (2017)

Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial
by: Eshleman S., et al.
Published: (2017)

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial
by: Beatriz Grinsztejn, et al.
Published: (2018)

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial
by: Beatriz Grinsztejn, et al.
Published: (2018)

HIV Vaccine Trials in Thailand and Path to HIV Cure
by: Leelarasamee A.
Published: (2023)

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated with Virologic Failure: Results from the Multinational PEARLS (ACTG A5175) Clinical Trial
by: Kantor R., et al.
Published: (2015)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
by: Philip J. Palumbo, et al.
Published: (2018)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
by: Philip J. Palumbo, et al.
Published: (2018)

HIV-1 prophylactic vaccine trials in Thailand
by: Punnee Pitisuttithum
Published: (2018)

"Why i am not infected with HIV": Implications for long-term HIV risk reduction and HIV vaccine trials
by: Don C. Des Jarlais, et al.
Published: (2018)

Estimation of HIV Incidence in a Large, Community-Based, Randomized Clinical Trial: NIMH Project Accept (HIV Prevention Trials Network 043)
by: Oliver Laeyendecker, et al.
Published: (2018)

Estimation of HIV Incidence in a Large, Community-Based, Randomized Clinical Trial: NIMH Project Accept (HIV Prevention Trials Network 043)
by: Oliver Laeyendecker, et al.
Published: (2018)

Prevention of HIV-1 infection with early antiretroviral therapy
by: Myron S. Cohen, et al.
Published: (2018)

Immune-correlates analysis of an HIV-1 vaccine efficacy trial
by: Barton F. Haynes, et al.
Published: (2018)

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV
by: Deborah Ford, et al.
Published: (2018)

Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries
by: Peter Lurie, et al.
Published: (2018)

Prophylactic HIV vaccine: vaccine regimens in clinical trials and potential challenges
by: Punnee Pitisuttithum, et al.
Published: (2020)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
by: Palumbo P., et al.
Published: (2017)

Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial
by: Annemarie E. Brouwer, et al.
Published: (2018)

Mothers' trial
by: Barbosa, Gabrielle Kristine Mortel, et al.
Published: (2023)

Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003
by: Michael Martin, et al.
Published: (2018)

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand
by: Punnee Pitisuttithum, et al.
Published: (2018)

Prevention of HIV-1 infection with early antiretroviral therapy
by: Cohen M., et al.
Published: (2017)

Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand
by: Richard A. Jenkins, et al.
Published: (2018)

Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand
by: Richard A. Jenkins, et al.
Published: (2018)

Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand
by: Kathleen M. MacQueen, et al.
Published: (2018)

Risk Behaviours and Comprehension among Intravenous Drug Users Volunteered for HIV Vaccine Trial
by: Punnee Pitisuttithum, et al.
Published: (2018)

Issues in women's participation in a phase III community HIV vaccine trial in Thailand
by: Jaranit Kaewkungwal, et al.
Published: (2018)

The ethics of placebo-controlled trials in developing countries to prevent mother-to-child transmission of HIV
by: WILLIAMS, John N.
Published: (2000)

HIV Surveillance in a Large, Community-Based Study: Results from the Pilot Study of Project Accept (HIV Prevention Trials Network 043)
by: Piwowar-Manning E., et al.
Published: (2017)

HIV Surveillance in a Large, Community-Based Study: Results from the Pilot Study of Project Accept (HIV Prevention Trials Network 043)
by: Estelle Piwowar-Manning, et al.
Published: (2018)